Health care startups that raised Series B in Nanjing, China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Tingsheng Technology | Nanjing | Series B | $13.9M | 2026-03-05 |
| Hope Medicine | Nanjing | Series B | $18.5M | 2024-09-27 |
| Tuge Medical Technology | Nanjing | Series B | $27.7M | 2024-04-10 |
| Chamlion | Nanjing | Series B | $34.3M | 2023-04-19 |
| Weiyun AI | Nanjing | Series B | $15.2M | 2021-03-30 |
5 rows of the CSV in 5 of its 18 columns.
- The 26 health care startups in Nanjing, China whose last round is Series B have raised $496.4M in total.
- 4 of them closed their most recent round in the last 12 months, $14.4M combined.
- The largest of those rounds is Tingsheng Technology's $13.9M Series B, dated March 2026.
- Qiming Venture Partners is an investor in 2 of them, more than any other fund.
- Biotech is the most common other sector, with 9 companies (35%).
- 8% were founded in 2020 or later; the median founding year is 2017.
- The most common team size is 1 to 10 employees (29% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
5 of 26| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Tingsheng Technology | Tingsheng Technology develops intracardiac ultrasound (ICE) products. | Health care | Series B | $13.9M | 2026-03-05 | $52.8M | Qiming Venture Partners, Taiyu Investment, Tao Capital +2 | 2017 | |
| Hope Medicine | Hope Medicine develops science-driven biopharmaceutical treatments in clinical development. | Health care | Series B | $18.5M | 2024-09-27 | $102.6M | Qiming Venture Partners, Sinovation Ventures, Trustbridge Partners +2 | 1 to 10 | 2018 |
| Tuge Medical Technology | Tuge Medical Technology develops and industrializes 4K endoscopic imaging equipment and digital operating rooms. | Health care | Series B | $27.7M | 2024-04-10 | $27.7M | LongRiver Investments | 101 to 250 | 2018 |
| Chamlion | Chamlion provides end-to-end digital dentistry solutions based on 3D printing. | Hardware | Series B | $34.3M | 2023-04-19 | Vertex Ventures China, Zhencheng Capital, 3H Health Investment +1 | 501 to 1,000 | 2017 | |
| Weiyun AI | Weiyun AI combines medical health and artificial intelligence to manufacture clinical dental products. | Artificial intelligence | Series B | $15.2M | 2021-03-30 | AlphaX Partners | 1 to 10 | 2018 |
Table 1. Health care startups that raised Series B in Nanjing, China: the 5 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 26.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Tingsheng Technology | Tingsheng Technology develops intracardiac ultrasound (ICE) products. | Health care | Series B | $13.9M | 2026-03-05 | $52.8M | Qiming Venture Partners, Taiyu Investment, Tao Capital +2 | 2017 |
Table 2. Health care startups that raised Series B in Nanjing, China: the 1 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Qiming Venture Partners | Venture capital firm | Shanghai, China | 2 | 8% | 1 | Tingsheng Technology |
| 2 | Titanium Capital | Hedge fund | North Palm Beach, United States | 1 | 4% | 1 | Tingsheng Technology |
| 3 | Taiyu Investment | Venture capital firm | Beijing, China | 1 | 4% | 1 | Tingsheng Technology |
| 4 | Tao Capital | Venture capital firm | Beijing, China | 1 | 4% | 1 | Tingsheng Technology |
| 5 | Huangpu River Capital | Private equity firm | Shanghai, China | 1 | 4% | 1 | Tingsheng Technology |
| 6 | Huatai Zijin Investment | Venture capital firm | Nanjing, China | 1 | 4% | 1 | Puguang Bio |
| 7 | Highlight Capital | Private equity firm | Nanjin, China | 1 | 4% | ||
| 8 | Wuxi Capital | Angel group | Wuxi Shi, China | 1 | 4% | ||
| 9 | Sinovation Ventures | Venture capital firm | Beijing, China | 1 | 4% | ||
| 10 | Trustbridge Partners | Private equity firm | Boston, United States | 1 | 4% | ||
| 11 | LongRiver Investments | Venture capital firm | Xuhui, China | 1 | 4% | ||
| 12 | Taihe Capital | Venture capital firm | Hangzhou, China | 1 | 4% | ||
| 13 | Vertex Ventures China | Venture capital firm | Beijing, China | 1 | 4% | ||
| 14 | Zhencheng Capital | Venture capital firm | Beijing, China | 1 | 4% | ||
| 15 | 3H Health Investment | Venture capital firm | Cyberport, Hong Kong | 1 | 4% |
Table 3. Health care startups that raised Series B in Nanjing, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
Table 4. Health care startups that raised Series B in Nanjing, China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series B | 26 | 100% | $14.4M |
Table 5. Health care startups that raised Series B in Nanjing, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| March 2026 | 1 | 25% | $13.9M |
| January 2026 | 1 | 25% | $483K |
| December 2025 | 1 | 25% | |
| November 2025 | 1 | 25% |
Table 6. Health care startups that raised Series B in Nanjing, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 2 | 8% | $14.4M |
| 2025 | 6 | 23% | $27.8M |
| 2024 | 2 | 8% | $46.1M |
| 2023 | 3 | 12% | $48.7M |
| 2022 | 6 | 23% | $90.2M |
| 2021 | 2 | 8% | $55.2M |
Table 7. Health care startups that raised Series B in Nanjing, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2020 to 2022 | 2 | 8% |
| 2015 to 2019 | 17 | 65% |
| 2010 to 2014 | 4 | 15% |
| Before 2010 | 3 | 12% |
Table 8. Health care startups that raised Series B in Nanjing, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 6 | 29% |
| 11 to 50 | 4 | 19% |
| 51 to 100 | 2 | 10% |
| 101 to 250 | 3 | 14% |
| 251 to 500 | 3 | 14% |
| 501 to 1,000 | 3 | 14% |
Table 9. Health care startups that raised Series B in Nanjing, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its most recent funding round is Series B and its headquarters is in Nanjing, China. On 16 November 2026 that is 26 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 5 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 26 rows: 8 have no round amount, 0 no city and 5 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Nanjing, China whose last round is Series B are on the list?
- 26, in the file dated 16 November 2026. 4 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 26 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.